Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
$114.03
+1.2%
$107.15
$88.96
$136.72
$2.10B0.81169,085 shs97,755 shs
Enhabit, Inc. stock logo
EHAB
Enhabit
$9.97
-2.7%
$9.17
$6.85
$10.91
$504.85M1.8460,316 shs790,287 shs
Progyny, Inc. stock logo
PGNY
Progyny
$21.55
-0.6%
$21.97
$13.39
$30.42
$1.86B1.321.70 million shs735,226 shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$66.37
-5.6%
$78.86
$24.91
$117.75
$1.89B1.94779,183 shs1.35 million shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
+1.19%+1.67%+3.91%+26.31%-3.73%
Enhabit, Inc. stock logo
EHAB
Enhabit
-2.47%-7.14%-5.05%+16.27%+6.06%
Progyny, Inc. stock logo
PGNY
Progyny
-0.65%+0.89%-0.60%+5.84%-22.26%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-5.62%-4.06%+8.93%-32.60%+143.29%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
4.7766 of 5 stars
3.62.00.05.02.82.52.5
Enhabit, Inc. stock logo
EHAB
Enhabit
1.0059 of 5 stars
1.03.00.00.01.40.02.5
Progyny, Inc. stock logo
PGNY
Progyny
0.9782 of 5 stars
1.21.00.00.02.62.51.3
GeneDx Holdings Corp. stock logo
WGS
GeneDx
3.603 of 5 stars
3.42.00.00.01.55.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
3.25
Buy$142.5725.03% Upside
Enhabit, Inc. stock logo
EHAB
Enhabit
2.00
Hold$8.50-14.74% Downside
Progyny, Inc. stock logo
PGNY
Progyny
2.42
Hold$23.458.84% Upside
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.75
Moderate Buy$86.7530.71% Upside

Current Analyst Ratings Breakdown

Latest EHAB, ADUS, WGS, and PGNY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/10/2025
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$133.00
5/15/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$88.00
5/12/2025
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$23.00 ➝ $21.00
5/9/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$80.00
5/8/2025
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.00
5/1/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$135.00 ➝ $110.00
5/1/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$105.00 ➝ $78.00
4/22/2025
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.00
4/10/2025
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.00
3/31/2025
Progyny, Inc. stock logo
PGNY
Progyny
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$28.00
(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
$1.21B1.73$5.27 per share21.65$43.58 per share2.62
Enhabit, Inc. stock logo
EHAB
Enhabit
$1.03B0.49$3.07 per share3.25$13.90 per share0.72
Progyny, Inc. stock logo
PGNY
Progyny
$1.21B1.52$0.61 per share35.58$5.77 per share3.73
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$330.14M5.74N/AN/A$8.78 per share7.56
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
$62.52M$4.4326.0921.271.416.50%9.62%7.37%8/4/2025 (Estimated)
Enhabit, Inc. stock logo
EHAB
Enhabit
-$80.50M-$2.77N/A34.38N/A-11.24%1.67%0.80%8/5/2025 (Estimated)
Progyny, Inc. stock logo
PGNY
Progyny
$62.04M$0.5737.1633.152.395.03%11.36%7.87%8/5/2025 (Estimated)
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$175.77M-$1.41N/A31.76N/A-17.12%3.33%1.69%7/29/2025 (Estimated)

Latest EHAB, ADUS, WGS, and PGNY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Progyny, Inc. stock logo
PGNY
Progyny
$0.45$0.17-$0.28$0.17$307.86 million$324.04 million
5/7/2025Q1 2025
Enhabit, Inc. stock logo
EHAB
Enhabit
$0.07$0.10+$0.03$0.35$266.11 million$259.90 million
5/5/2025Q1 2025
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
$1.33$1.42+$0.09$1.16$341.66 million$337.71 million
4/30/2025Q1 2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$0.11$0.28+$0.17-$0.23$79.90 million$87.12 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
N/AN/AN/AN/AN/A
Enhabit, Inc. stock logo
EHAB
Enhabit
N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
N/A
2.11
2.11
Enhabit, Inc. stock logo
EHAB
Enhabit
0.85
1.46
1.46
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.62
2.62
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.25
2.40
2.27

Institutional Ownership

CompanyInstitutional Ownership
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
95.35%
Enhabit, Inc. stock logo
EHAB
Enhabit
N/A
Progyny, Inc. stock logo
PGNY
Progyny
94.93%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
61.72%

Insider Ownership

CompanyInsider Ownership
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
4.60%
Enhabit, Inc. stock logo
EHAB
Enhabit
3.40%
Progyny, Inc. stock logo
PGNY
Progyny
9.40%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
29.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Addus HomeCare Co. stock logo
ADUS
Addus HomeCare
33,20018.40 million17.30 millionOptionable
Enhabit, Inc. stock logo
EHAB
Enhabit
10,90050.64 million49.33 millionOptionable
Progyny, Inc. stock logo
PGNY
Progyny
31085.72 million74.68 millionOptionable
GeneDx Holdings Corp. stock logo
WGS
GeneDx
1,20028.53 million19.97 millionOptionable

Recent News About These Companies

These 24 Stocks Are Ripe for a Short Squeeze

New MarketBeat Followers Over Time

Media Sentiment Over Time

Addus HomeCare stock logo

Addus HomeCare NASDAQ:ADUS

$114.03 +1.34 (+1.19%)
As of 06/12/2025 04:00 PM Eastern

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Enhabit stock logo

Enhabit NYSE:EHAB

$9.97 -0.28 (-2.73%)
As of 06/12/2025 03:59 PM Eastern

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

Progyny stock logo

Progyny NASDAQ:PGNY

$21.55 -0.14 (-0.65%)
As of 06/12/2025 04:00 PM Eastern

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

GeneDx stock logo

GeneDx NASDAQ:WGS

$66.37 -3.95 (-5.62%)
Closing price 06/12/2025 04:00 PM Eastern
Extended Trading
$65.23 -1.14 (-1.71%)
As of 07:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.